Alemtuzumab Induction and Prednisone‐Free Maintenance Immunotherapy in Kidney Transplantation: Comparison with Basiliximab Induction—Long‐Term Results
Open Access
- 1 May 2005
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 5 (10), 2539-2548
- https://doi.org/10.1111/j.1600-6143.2005.01067.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Reduction of CMV Disease with Steroid-Free Immunosuppresssion in Simultaneous Pancreas–Kidney Transplant RecipientsAmerican Journal of Transplantation, 2005
- Proposal for Guidelines for Publication of Randomized Trials in the American Journal of TransplantationAmerican Journal of Transplantation, 2005
- A Multicenter Pilot Study of Early (4-Day) Steroid Cessation in Renal Transplant Recipients Under Simulect, Tacrolimus and SirolimusAmerican Journal of Transplantation, 2005
- Long-term Immunosuppression, Without Maintenance Prednisone, After Kidney TransplantationAnnals of Surgery, 2004
- Early Adequate Mycophenolic Acid Exposure is Associated with Less Rejection in Kidney TransplantationAmerican Journal of Transplantation, 2004
- Steroid-Withdrawal at 3 Days After Renal Transplantation with Anti-IL-2 Receptor α Therapy: A Prospective, Randomized, Multicenter StudyAmerican Journal of Transplantation, 2004
- RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)Transplantation, 2003
- Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1Transplantation, 2003
- Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigenMolecular Immunology, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958